A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

Clinical trial NCT04478279 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04478279
Sponsor: Sapience Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Melanoma Stage IV Breast Cancer Prostate Cancer Glioblastoma Multiforme GBM Brain Cancer Metastatic Breast Cancer Metastatic Melanoma Metastatic Prostate Cancer Melanoma Recurrent Prostate Cancer Metastatic

Start date: 2020-07-01
Primary completion: 2026-12-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.